Published in the Commonwealth of Australia Gazette No. GN 45, 10 November 2004
Therapeutic Goods Act 1989
I, TERRY SLATER, National Manager, Therapeutic Goods Administration, delegate of the Parliamentary Secretary to the Minister for Health and Ageing for the purposes of subsection 9A (5) of the Therapeutic Goods Act 1989 and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods for listed goods:
preparations, referred to in Item 3, Part 1 of Schedule 4 of the Therapeutic Goods Regulations 1990, that contain, as their therapeutically active ingredient, any one of the following substances:
amylase derived from Aspergillus oryzae,
tilactase derived from Aspergillus oryzae,
protease derived from Aspergillus oryzae,
cellulase derived from Trichoderma longibrachiatum,
lipase derived from Rhizopus oryzae,
being substances that are to be mentioned in Division 1 of Part 5 of Schedule 4 of the Therapeutic Goods Regulations 1990.
This Notice comes into effect on the date it is gazetted.
Dated 1 November 2004
Terry Slater National Manager, Therapeutic Goods Administration Delegate of the Parliamentary Secretary
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.